Anhui Highfine Biotech Co., Ltd. is located in the high-tech zone of Anqing. It was established in September 2018 with a registered capital of 100 million RMB. It is a subsidiary of Suzhou Highfine Biotech Co., Ltd. Covering an area of 59,000 m2, with a total investment of 300 million RMB, it was completed and put into operation in 2021. The second woekshop has been completed and put into operation in February 2024, While the third workshops are under planning and construction.
There are comprehensive office buildings, research and development centers, 3 production workshops, raw materials and finished products warehouses, and other facilities. DCS automatic control system improves production efficiency and safety. It is mainly used to carry out the projects of peptide reagents and protein cross-linking agents.
